Belimumab Reduces the Frequency of Flares in Patients with Refractory SLE: DATA from Clinical Practice Setting

被引：0
|
作者：
Doria, Andrea [1 ]
Iaccarino, Luca [1 ]
Bettio, Silvano [1 ]
Frassi, Micol [2 ,3 ]
Andreoli, Laura [2 ,3 ]
Reggia, Rossella [2 ,3 ]
Zen, Margherita [1 ]
Nalotto, Linda [1 ]
Gatto, Mariele [1 ]
Pea, Lara [2 ,3 ]
Punzi, Leonardo [1 ]
Tincani, Angela [2 ,3 ]
机构：
[1] Univ Padua, Padua, Italy
[2] Spedali Civil Brescia, I-25125 Brescia, Italy
[3] Univ Brescia, Brescia, Italy
来源：
ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
671
引用
收藏
页码：S292 / S293
页数：2
相关论文
共 50 条
  • [1] Belimumab Reduces the Frequency of Flares and Prevents Damage Progression in SLE Patients: Experience in a Clinical Practice Setting
    Iaccarino, Luca
    Bettio, Silvano
    Reggia, Rossella
    Zen, Margherita
    Frassi, Micol
    Andreoli, Laura
    Nalotto, Linda
    Gatto, Mariele
    Pea, Lara
    Bassi, Nicola
    Larosa, Maddalena
    Zanola, Alessandra
    Punzi, Leonardo
    Tincani, Angela
    Doria, Andrea
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [2] Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies
    Francesca Trentin
    Mariele Gatto
    Margherita Zen
    Larosa Maddalena
    Linda Nalotto
    Francesca Saccon
    Elisabetta Zanatta
    Luca Iaccarino
    Andrea Doria
    Clinical Reviews in Allergy & Immunology, 2018, 54 : 331 - 343
  • [3] Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies
    Trentin, Francesca
    Gatto, Mariele
    Zen, Margherita
    Maddalena, Larosa
    Nalotto, Linda
    Saccon, Francesca
    Zanatta, Elisabetta
    Iaccarino, Luca
    Doria, Andrea
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2018, 54 (02) : 331 - 343
  • [4] Correction to: Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies
    Francesca Trentin
    Mariele Gatto
    Margherita Zen
    Maddalena Larosa
    Linda Nalotto
    Francesca Saccon
    Elisabetta Zanatta
    Luca Iaccarino
    Andrea Doria
    Clinical Reviews in Allergy & Immunology, 2018, 54 : 494 - 494
  • [5] Correction to: Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies
    Francesca Trentin
    Mariele Gatto
    Margherita Zen
    Maddalena Larosa
    Linda Nalotto
    Francesca Saccon
    Elisabetta Zanatta
    Luca Iaccarino
    Andrea Doria
    Clinical Reviews in Allergy & Immunology, 2018, 55 : 237 - 237
  • [6] SLEDAI-2K AND POLYARTHRITIS ARE THE BEST PREDICTORS OF RESPONSE TO BELIMUMAB IN PATIENTS WITH ACTIVE SLE IN CLINICAL PRACTICE SETTING: DATA FROM MULTI CENTRIC ITALIAN STUDY
    Bettio, S.
    Iaccarino, L.
    Reggia, R.
    Emmi, G.
    Ceccarelli, F.
    Ubiali, T.
    Bortoluzzi, A.
    De Marchi, G.
    Bocci, E. Bartoloni
    Andreoli, L.
    Zen, M.
    Emmi, L.
    Conti, F.
    Gerosa, M.
    Meroni, P. L.
    Govoni, M.
    De Vita, S.
    Gerli, R.
    Tincani, A.
    Doria, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : S12 - S12
  • [7] Response to Belimumab in SLE Patients with High Disease Activity: Data from a Multicentric Clinical-Practice Based Study Cohort
    Iaccarino, Luca
    Bettio, Silvano
    Reggia, Rossella
    Emmi, Giacomo
    Ceccarelli, Fulvia
    Tani, Chiara
    Gerosa, Maria
    Govoni, Marcello
    Bortoluzzi, Alesandra
    De Vita, Salvatore
    De Marchi, Ginevra
    De Angelis, Rossella
    Di Matteo, Andrea
    Salvarani, Carlo
    Pazzola, Giulia
    Bartoloni-Bocci, Elena
    Andreoli, Laura
    Zen, Margherita
    Conti, Fabrizio
    Mosca, Marta
    Meroni, Pier Luigi
    Gerli, Roberto
    Tincani, Angela
    Doria, Andrea
    Emmi, Lorenzo
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [8] EARLY CLINICAL IMPROVEMENT IN SLE PATIENTS TREATED WITH BELIMUMAB
    Doria, A.
    Sanchez-Guerrero, J.
    Tegzova, D.
    Ginzler, E. M.
    Zhong, Z. J.
    Dennis, G.
    Wallace, D. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 535 - 535
  • [9] Belimumab reduces antiphospholipid antibodies in SLE patients independently of hydroxychloroquine treatment
    Emmi, Giacomo
    Bettiol, Alessandra
    Palterer, Boaz
    Silvestri, Elena
    Vitiello, Gianfranco
    Parronchi, Paola
    Prisco, Domenico
    AUTOIMMUNITY REVIEWS, 2019, 18 (03) : 312 - 314
  • [10] BELIMUMAB, A BLYS-SPECIFIC INHIBITOR, REDUCES DISEASE ACTIVITY AND SEVERE FLARES IN SEROPOSITIVE SLE PATIENTS: BLISS-76 STUDY
    van Vollenhoven, R.
    Zamani, O.
    Wallace, D.
    Tegzova, D.
    Merrill, J.
    Chatham, W.
    Schwarting, A.
    Hiepe, F.
    Doria, A.
    Sanchez-Guerrero, J.
    Jeka, S.
    Dyczek, A.
    Furie, R.
    Petri, M.
    D'Cruz, D.
    Fojtik, Z.
    Pineda, L.
    Zhong, Z.
    Hough, D.
    Freimuth, W.
    Cervera, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (01) : 215 - 215
12345